KPV, also known as Lysine-Proline-Valine, is a synthetic tripeptide derived from the alpha-melanocyte-stimulating hormone sequence. It is designed to interact with inflammatory signaling pathways and cellular regulatory mechanisms associated with immune response. This compound is studied for its role in modulating cytokine activity and peptide-mediated signaling processes. Commonly utilized in research settings to investigate inflammatory response, cellular repair signaling, and regulatory pathway interactions. Supplied by Peptico for research-use only.
SIZE:
Out of stock
All Orders Ship within
24 Business Hours
Free Shipment Protection
Priority Shipment Options Available at Checkout
Format
Lyophilized powder
Approved Exclusively For
Laboratory and Analytical Research
Handling
Utilize appropriate sterile technique and controlled environments during preparation.
Short-Term Storage - Lyophilized Powder Form Only
- For maximum potency, lyophilized materials may generally be stored between 2°C and 8°C (36°F to 46°F) for up to 4 weeks when maintained in their original, sealed lyophilized form.
- Maintain a cool and dry environment.
- Protect from moisture and light.
- Minimize exposure to humidity and temperature fluctuations.
Long-Term Storage - Lyophilized Powder Form Only
- For maximum potency and long-term preservation, lyophilized materials may generally be stored between -20°C and -80°C (-4°F to -112°F) for up to 1 year when preserved in their original, sealed lyophilized form.
- Maintain a cool and dry environment.
- Protect from moisture and light.
- Minimize exposure to humidity and temperature fluctuations.
Important Note:
Storage guidelines apply only to lyophilized material in its original, sealed, and untampered vial.
COA History
All shipped products include a unique batch number printed on the vial label. This batch number corresponds to a third-party Certificate of Analysis tested by an ISO/IEC 17025 accredited laboratory.
The COA attached at the top of this page, along with the COA marked “Current” below, represents the active production batch currently being shipped. This same batch number will appear on the label of your vial.
For previous purchases, please refer to COAs marked “Historical” and match the batch number on your vial to the batch number listed on the corresponding COA.
For a complete record of testing documentation across all products and batches, please visit our COA Vault, which includes both current and historical COAs.
Loading COA history...
Molecular Profile
What is KPV?
Scientific compound data sourced from PubChem.
Chemical Structure
PubChem CID 90474670
Type
Peptide compound
PubChem CID
90474670
CAS Number
2828433-34-5
Molecular Formula
C18H34N4O6
Molecular Weight
402.50 g/mol
IUPAC Name
acetic acid;(2S)-2-[[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoic acid
InChIKey
ZQWQMTOELXHBPM-QKWXXBCPSA-N
Research
Sources & References
API results related to KPV.
PubMed
Scientific paper
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review.
The Journal of sports medicine and physical fitness
Publication date: 2026 Jul
View source
PubMed
Scientific paper
Lysine-proline-valine peptide attenuates hepatic lipid accumulation through ROS-dependent regulation of the PPARγ pathway in HepG2 cells.
Cytotechnology
Publication date: 2026 Jun
View source
PubMed
Scientific paper
Inflammation-triggered self-immolative conjugates enable oral peptide delivery by overcoming gastrointestinal barriers.
Science advances
Publication date: 2026 Jan 16
View source
PubMed
Scientific paper
Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway.
Tissue & cell
Publication date: 2025 Aug
View source
PubMed
Scientific paper
KPV and RAPA Self-Assembled into Carrier-Free Nanodrugs for Vascular Calcification Therapy.
Advanced healthcare materials
Publication date: 2024 Dec
View source
PubMed
Scientific paper
PepT1-targeted nanodrug based on co-assembly of anti-inflammatory peptide and immunosuppressant for combined treatment of acute and chronic DSS-induced ColitiS.
Frontiers in pharmacology
Publication date: 2024
View source⚠️ IMPORTANT RESEARCH NOTICE
This product is NOT for human consumption.
Supplied strictly for laboratory and analytical research use only, it is not intended to diagnose, treat, cure, or prevent any disease, and must not be used for clinical, veterinary, or therapeutic applications.
All information provided, including referenced research and data, is for educational and scientific context only and should NOT be interpreted as medical guidance.
By purchasing, you confirm that you are a qualified individual or entity operating in accordance with applicable local, state, and federal regulations. All responsibility for handling, use, and compliance rests solely with the purchaser.
